Akorn
Top Ten most popular articles on Pharmafile.com this week!
December 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10
Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
Akorn CEO resigns after $4.3bn Fresenius deal falls through
December 10, 2018Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics
The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …
Fresenius confirms takeover talks with Akorn
April 10, 2017Sales and Marketing Akorn, Fresenius
Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …
Pfizer pays $63m for generics portfolio
January 5, 2011Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables
Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
